Skip to main content

Nanotherapeutics for Treating Neurodegenerative Disorders

  • 1st Edition - July 1, 2026
  • Latest edition
  • Editors: Manish K. Chourasia, Shubhini A. Saraf, Yashwant Pathak, Mohini Chaurasia
  • Language: English

Nanotherapeutics for Treating Neurodegenerative Disorders reviews the complex landscape of neurodegenerative disorders, outlining the nuances of treatment strategies and the impera… Read more

World Book Day celebration

Where learning shapes lives

Up to 25% off trusted resources that support research, study, and discovery.

Description

Nanotherapeutics for Treating Neurodegenerative Disorders reviews the complex landscape of neurodegenerative disorders, outlining the nuances of treatment strategies and the imperative role of nanotechnology in revolutionizing therapeutic interventions. From explaining the transport mechanisms of the Blood-Brain Barrier to unveiling the therapeutic potential of stem cell-derived nanocarriers, each chapter offers invaluable insights into the diverse array of nanotherapeutic approaches helping to reshape the landscape of neurological healthcare. By consolidating current updates on advanced targets-based nanotherapeutics, this book provides a comprehensive resource for neurodegenerative diseases converge.

Whether seeking to unravel the complexities of mitochondrial dysfunction or to harness the potential of nanocarriers for targeted genetic material delivery, readers will find themselves equipped with the tools to navigate the forefront of neurotherapeutic innovation.

Key features

  • Reviews the complexities of treatment strategies and the transformative role of nanotechnology in reshaping therapeutic interventions
  • Offers a diverse array of insights, providing readers with invaluable knowledge across a spectrum of nanotherapeutic approaches
  • Provides current updates on advanced, targets-based nanotherapeutics

Readership

Researchers in the field of neuroscience and aging biology, pharmacology, pharmaceutics, toxicology and experimental medicines, drug discovery and development

Table of contents

1. Concepts, types, and treatment strategies for neurodegenerative disorders

2. Transport mechanisms of the Blood-Brain Barrier

3. Need of nanotherapeutics against neurodegenerative disorders

4. Nanotechnology mediated drug delivery for addressing protein aggregation

5. Nanocarriers focusing on synuclein misfolding as a therapeutic target

6. Therapeutic potential of stem cells derived nanocarriers in neurological disorders

7. Emphasizing mitochondrial dysfunction and autophagy in the treatment of neurological disorders

8. Nanocarriers assisted delivery of genetic material for the treatment of neurodegenerative disorders

9. Nanotherapeutics targeting neuroinflammation

10. Nanocarriers mediated DNA repair mechanism against neurological disorders

11. Nanotherapy for targeted inhibition of PERK: Unravelling stress-induced endoplasmic reticulum kinase

12. Targeting microglial inhibition via nanotechnology: A strategy to halt protein degradation

13. Nanocarriers unveiling ferroptosis as a potential therapeutic target

14. Proteostasis maintenance through nanocarriers: Mitigating protein misfolding, mitochondrial impairment, and oxidative stress

15. Modulation of Hippo signaling pathway dysregulation through nanotechnology for neurodegenerative disorders

16. Nanocarriers modulating fibrinolytic pathways for the treatment of various neurological disorders

17. Targeting glial cells through nanotherapeutic strategies in neurological disorders

18. Oligodendrocytes as an emerging therapeutic target in neurological disorders

Product details

  • Edition: 1
  • Latest edition
  • Published: July 1, 2026
  • Language: English

About the editors

MC

Manish K. Chourasia

Dr. Manish K. Chourasia, is currently working as a Senior Principal Scientist in the Division of Pharmaceutics and Pharmacokinetics at CSIR-Central Drug Research Institute (CDRI), Lucknow, a premium drug research institute in India. He received his PhD in Pharmaceutical Sciences from Dr. Harisingh Gour University, Madhya Pradesh, India and carried out his post-doctoral studies at Department of Pharmacy, National University of Singapore, Singapore. Having acquired valuable experience in both industry and academia, he subsequently joined the role of a scientist at CSIR-CDRI almost two decades ago. He has played a significant role in advancing the field of nanoparticle-based drug delivery for breast cancer, aiming to enhance the therapeutic outcome. He has published 80+ scientific papers including high-impact journal reviews. He has supervised more than 50 MS students and PhD students.

Affiliations and expertise
CSIR-Central Drug Research, India

SS

Shubhini A. Saraf

Prof. Shubhini A. Saraf is working as Director of the National Institute of Pharmaceutical Education and Research (NIPER), Raebareli (U.P.). Before joining NIPER, Raebareli, she worked as a Professor in the Department of Pharmaceutical Sciences and Director (R&D) at Babasaheb Bhimrao Ambedkar University (A Central University), Lucknow. She also served in various administrative positions at BBA University Lucknow and B.B.D.N.I.T.M. Lucknow including Head-Pharmaceutical Sciences, Dean- School of Biomedical and Pharmaceutical Sciences, Dean- School of Biosciences & Biotechnology, member of the Board of Management, Director, E.M.M.R.C. at BBAU, Lucknow and Director B.B.D.N.I.T.M. Lucknow. Prof. Shubhini is an alumnus of the Department of Pharmaceutical Sciences, Dr Harisingh Gour University, Sagar where she pursued her B. Pharm, M. Pharm, and Ph.D. in Pharmacy. She has more than 28 years of teaching and research experience. Her research interests include Nanotechnology & Drug Targeting as well as Technology Policy Interventions for Health Care. She has 167 papers, and 21 book chapters to her credit and is an active pharmacy professional.

Affiliations and expertise
National Institute of Pharmaceutical Education and Research, India

YP

Yashwant Pathak

Yashwant Pathak, is Professor, Taneja College of Pharmacy, at the University of South Florida. Tampa, USA. His area of research is nanotechnology, drug delivery systems and nutraceuticals. He is also Adjunct Professor at Faculty of Pharmacy, Airlangga University, Surabaya, Indonesia.

Affiliations and expertise
Professor, Taneja College of Pharmacy, University of South Florida, Tampa FL 33612 and Adjunct Professor , Faculty of Pharmacy, Airlangga University, Surabaya, Indonesia

MC

Mohini Chaurasia

Dr. Mohini Chaurasia stands as a distinguished figure in the field of pharmaceutical education, currently holding the positions of Professor and Principal at Era College of Pharmacy, Era University, Lucknow, India. With a career spanning various academic institutions, including Amity University and Integral University, Dr. Chaurasia has garnered extensive experience, contributing significantly to the field. Her academic journey boasts a culmination in her current role, driving both research and institutional leadership. Dr. Chaurasia's expertise extends beyond teaching to innovative research, evident in her publications and patents. In the field of drug delivery, she has edited books like "Novel Carriers for Drug Delivery" and "Oral Modified Release Drug Delivery Systems," showcasing her depth of knowledge. Moreover, her research contributions include impactful chapters on drug delivery systems and nanotechnology applications in drug development. Beyond her scholarly pursuits, Dr. Chaurasia actively engages in various academic and administrative responsibilities, serving on boards, committees, and taking up leadership roles.

Affiliations and expertise
Era College of Pharmacy, Era University, India